p38 Cancer Research Results

p38, p38: Click to Expand ⟱
Source:
Type:
P38, or p38 MAPK (p38 mitogen-activated protein kinase), is a protein kinase that plays a significant role in cellular responses to stress, inflammation, and apoptosis (programmed cell death). It is part of the MAPK signaling pathway, which is involved in various cellular processes, including cell growth, differentiation, and survival.
It can have both tumor-suppressive and tumor-promoting effects, depending on the type of cancer and the cellular context.

-p38 activation can contribute to tumor progression by influencing inflammatory signaling and cell-cycle regulation.
-Overexpression can correlate with poor prognosis in some studies.


Scientific Papers found: Click to Expand⟱
2085- TQ,    Anticancer Activities of Nigella Sativa (Black Cumin)
- Review, Var, NA
MMP↓, Casp3↑, Casp8↑, Casp9↓, cl‑PARP↑, Cyt‑c↑, Bax:Bcl2↑, NF-kB↓, IAP1↓, IAP2↓, XIAP↓, Bcl-xL↓, survivin↓, cJun↑, p38↑, Akt↑, chemoP↑, *radioP↑,
2102- TQ,    A review on therapeutic potential of Nigella sativa: A miracle herb
- Review, Var, NA
angioG↓, NF-kB↓, PPARγ↓, Bcl-2↓, Bcl-xL↓, MUC4↓, cJun↑, p38↑, P21↑, HDAC↓, *radioP↑, hepatoP↑,
3411- TQ,    Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone
- Review, Var, NA
p‑STAT3↓, cycD1/CCND1↓, JAK2↓, β-catenin/ZEB1↓, cMyc↓, MMP7↓, MET↓, p‑Akt↓, p‑mTOR↓, CXCR4↓, Bcl-2↓, BAX↑, ROS↑, Cyt‑c↑, Twist↓, Zeb1↓, E-cadherin↑, p‑p38↑, p‑MAPK↑, ERK↑, eff↑, ERK↓, TumCP↓, TumCMig↓, TumCI↓,
3398- TQ,  5-FU,    Impact of thymoquinone on the Nrf2/HO-1 and MAPK/NF-κB axis in mitigating 5-fluorouracil-induced acute kidney injury in vivo
- in-vivo, Nor, NA
*RenoP↑, *TAC↑, *ROS↓, *lipid-P↓, *p38↓, *MAPK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *MDA↓, *GPx↑, *GSR↑, *Catalase↑, *BUN↓, *LDH↓, *IL1β↓,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
3425- TQ,    Advances in research on the relationship between thymoquinone and pancreatic cancer
Apoptosis↑, TumCP↓, TumCI↓, TumMeta↓, ChemoSen↑, angioG↓, Inflam↓, NF-kB↓, PI3K↓, Akt↓, TGF-β↓, Jun↓, p38↑, MAPK↑, MMP9↓, PKM2↓, ROS↑, JNK↑, MUC4↓, TGF-β↑, Dose↝, FAK↓, NOTCH↓, PTEN↑, mTOR↓, Warburg↓, XIAP↓, COX2↓, Casp9↑, Ki-67↓, CD34↓, VEGF↓, MCP1/CCL2↓, survivin↓, Cyt‑c↑, Casp3↑, H4↑, HDAC↓,
3427- TQ,    Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
ROS⇅, Fas↑, DR5↑, TRAIL↑, Casp3↑, Casp8↑, Casp9↑, P53↑, mTOR↓, Bcl-2↓, BID↓, CXCR4↓, JNK↑, p38↑, MAPK↑, LC3II↑, ATG7↑, Beclin-1↑, AMPK↑, PPARγ↑, eIF2α↓, P70S6K↓, VEGF↓, ERK↓, NF-kB↓, XIAP↓, survivin↓, p65↓, DLC1↑, FOXO↑, TET2↑, CYP1B1↑, UHRF1↓, DNMT1↓, HDAC1↓, IL2↑, IL1↓, IL6↓, IL10↓, IL12↓, TNF-α↓, iNOS↓, COX2↓, 5LO↓, AP-1↓, PI3K↓, Akt↓, cMET↓, VEGFR2/KDR/Flk1↓, CXCL1↓, ITGA5↓, Wnt↓, β-catenin/ZEB1↓, GSK‐3β↓, Myc↓, cycD1/CCND1↓, N-cadherin↓, Snail↓, Slug↓, Vim↓, Twist↓, Zeb1↓, MMP2↓, MMP7↓, MMP9↓, JAK2↓, STAT3↓, NOTCH↓, cycA1/CCNA1↓, CDK2↓, CDK4↓, CDK6↓, CDC2↓, CDC25↓, Mcl-1↓, E2Fs↓, p16↑, p27↑, P21↑, ChemoSen↑,
4833- Uro,    Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine
- Review, Var, NA - Review, AD, NA - Review, IBD, NA
BioAv↝, TumAuto↝, TumCG↓, TumMeta↓, ChemoSen↑, Imm↑, RadioS↑, BioAv↑, other↝, eff↓, *antiOx↓, *Inflam↓, AntiCan↓, AntiAge↑, chemoP↑, *neuroP↑, *ROS↓, *cognitive↑, *lipid-P↓, *cardioP↑, *TNF-α↓, *IL6↓, GutMicro↑, TumCCA↑, Apoptosis↑, angioG↓, NF-kB↓, PI3K↓, Akt↓, Casp↑, survivin↓, TumCP↓, cycD1/CCND1↓, cMyc↑, BAX↑, Bcl-2↓, COX2↓, P53↑, p38↑, *ROS↓, *SOD↑, *GPx↑, SIRT1↑, FOXO1↑, eff↑, ChemoSen↑,
3116- VitC,    p38%20mitogen-activated%20protein%20kinase.pdf;sequence=1">Vitamin C Inhibits NF-kB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase
- in-vitro, Nor, ECV304 - in-vitro, Nor, HUVECs
*NF-kB↓, *p38↑, *MAPK↑,
3128- VitC,    Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages
- in-vitro, Nor, NA
*ROS↓, *DNAdam↓, *TNF-α↓, *IL6↓, *p38↓,
1817- VitK2,    Research progress on the anticancer effects of vitamin K2
- Review, Var, NA
TumCCA↑, Apoptosis↑, TumAuto↑, TumCI↓, TumCG↓, ChemoSen↓, ChemoSideEff↓, toxicity∅, eff↑, cycD1/CCND1↓, CDK4↓, eff↑, IKKα↓, NF-kB↓, other↑, p27↑, cMyc↓, i-ROS↑, Bcl-2↓, BAX↑, p38↑, MMP↓, Casp9↑, p‑ERK↓, RAS↓, MAPK↓, p‑P53↑, Casp8↑, Casp3↑, cJun↑, MMPs↓, eff↑, eff↑,
1818- VitK2,    New insights on vitamin K biology with relevance to cancer
- Review, Var, NA
TumCG↓, ChemoSen↑, toxicity∅, OS↑, BMD↑, eff↑, MMP↓, ROS↑, eff↓, ERK↑, JNK↑, p38↑, Cyt‑c↑, Casp↑, ATP↓, lactateProd↑, AMPK↑, Rho↓, TumCG↓, BioAv↑, cardioP↑, Risk↓,
2277- VitK2,    Vitamin K2 suppresses rotenone-induced microglial activation in vitro
- in-vitro, Nor, BV2 - NA, AD, NA - NA, Park, NA
*p38↓, *ROS↓, *Casp1↓, *MMP↑, *NF-kB↓, *IL1β↓, *iNOS↓, *COX2↓, *TNF-α↓,
2279- VitK2,    Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways
- in-vitro, Bladder, T24/HTB-9 - in-vitro, Bladder, J82 - in-vitro, Nor, HEK293 - in-vitro, Nor, L02 - in-vivo, NA, NA
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,

Showing Research Papers: 151 to 164 of 164
Prev Page 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 164

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

ROS↑, 4,   ROS⇅, 2,   i-ROS↑, 1,  

Mitochondria & Bioenergetics(tgid=3)

ATP↓, 1,   CDC2↓, 1,   CDC25↓, 1,   MMP↓, 4,   XIAP↓, 3,  

Core Metabolism/Glycolysis(tgid=4)

AMPK↑, 2,   ATG7↑, 1,   cMyc↓, 3,   cMyc↑, 1,   lactateProd↑, 1,   PKM2↓, 1,   PPARγ↓, 1,   PPARγ↑, 1,   SIRT1↑, 1,   Warburg↓, 1,  

Cell Death(tgid=5)

Akt↓, 4,   Akt↑, 1,   p‑Akt↓, 1,   Apoptosis↑, 4,   BAX↑, 4,   Bax:Bcl2↑, 1,   Bcl-2↓, 5,   Bcl-2↑, 1,   Bcl-xL↓, 2,   BID↓, 1,   Casp↑, 2,   Casp3↑, 6,   Casp7↑, 1,   Casp8↑, 3,   Casp9↓, 1,   Casp9↑, 4,   Cyt‑c↑, 5,   DR5↑, 1,   Fas↑, 1,   IAP1↓, 1,   IAP2↓, 1,   iNOS↓, 1,   JNK↑, 4,   p‑JNK↑, 1,   MAPK↓, 1,   MAPK↑, 2,   p‑MAPK↑, 1,   Mcl-1↓, 1,   Myc↓, 1,   p27↑, 3,   p38↑, 8,   p‑p38↑, 2,   survivin↓, 5,   TRAIL↑, 1,  

Transcription & Epigenetics(tgid=7)

cJun↑, 3,   H4↑, 1,   other↑, 1,   other↝, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8)

eIF2α↓, 1,  

Autophagy & Lysosomes(tgid=9)

Beclin-1↑, 1,   LC3II↑, 1,   TumAuto↑, 1,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10)

CYP1B1↑, 1,   DNMT1↓, 1,   p16↑, 1,   P53↑, 2,   p‑P53↑, 1,   cl‑PARP↑, 2,   UHRF1↓, 1,  

Cell Cycle & Senescence(tgid=11)

CDK2↓, 1,   CDK4↓, 2,   cycA1/CCNA1↓, 1,   cycD1/CCND1↓, 5,   E2Fs↓, 1,   P21↑, 3,   TumCCA↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12)

CD34↓, 1,   cMET↓, 1,   EMT↓, 1,   ERK↓, 3,   ERK↑, 2,   p‑ERK↓, 1,   FOXO↑, 1,   FOXO1↑, 1,   GSK‐3β↓, 2,   HDAC↓, 2,   HDAC1↓, 1,   Jun↓, 1,   mTOR↓, 3,   p‑mTOR↓, 1,   NOTCH↓, 2,   P70S6K↓, 1,   PI3K↓, 4,   PTEN↑, 2,   RAS↓, 1,   STAT3↓, 2,   p‑STAT3↓, 1,   TumCG↓, 4,   Wnt↓, 1,  

Migration(tgid=13)

5LO↓, 1,   AP-1↓, 1,   DLC1↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 1,   FAK↓, 1,   ITGA5↓, 1,   Ki-67↓, 1,   MET↓, 1,   MMP2↓, 1,   MMP7↓, 2,   MMP9↓, 2,   MMPs↓, 2,   MUC4↓, 2,   N-cadherin↓, 1,   Rho↓, 1,   Slug↓, 1,   Snail↓, 1,   TGF-β↓, 1,   TGF-β↑, 1,   TumCI↓, 3,   TumCMig↓, 1,   TumCP↓, 4,   TumMeta↓, 3,   Twist↓, 3,   Vim↓, 1,   Zeb1↓, 2,   β-catenin/ZEB1↓, 3,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 3,   angioG↑, 1,   VEGF↓, 3,   VEGFR2/KDR/Flk1↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 3,   CXCL1↓, 1,   CXCR4↓, 2,   IKKα↓, 1,   IL1↓, 1,   IL10↓, 1,   IL12↓, 1,   IL2↑, 1,   IL6↓, 1,   Imm↑, 1,   Inflam↓, 1,   JAK2↓, 2,   MCP1/CCL2↓, 1,   NF-kB↓, 6,   p‑NF-kB↑, 1,   p65↓, 1,   TNF-α↓, 1,  

Hormonal & Nuclear Receptors(tgid=20)

CDK6↓, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↑, 2,   BioAv↝, 1,   ChemoSen↓, 1,   ChemoSen↑, 6,   Dose↝, 1,   eff↓, 3,   eff↑, 7,   RadioS↑, 1,   selectivity↑, 2,   TET2↑, 1,  

Clinical Biomarkers(tgid=22)

BMD↑, 1,   GutMicro↑, 1,   IL6↓, 1,   Ki-67↓, 1,   Myc↓, 1,  

Functional Outcomes(tgid=23)

AntiAge↑, 1,   AntiCan↓, 1,   cardioP↑, 1,   chemoP↑, 3,   ChemoSideEff↓, 1,   hepatoP↑, 1,   OS↑, 1,   Risk↓, 1,   toxicity∅, 2,   TumVol↓, 1,  
Total Targets: 174

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

antiOx↓, 1,   antiOx↑, 1,   Catalase↑, 2,   GPx↑, 3,   GSR↑, 1,   GSTA1↑, 1,   HO-1↑, 1,   lipid-P↓, 2,   MDA↓, 1,   NRF2↑, 1,   ROS↓, 5,   SOD↑, 2,   TAC↑, 1,  

Mitochondria & Bioenergetics(tgid=3)

MMP↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

BUN↓, 1,   LDH↓, 1,  

Cell Death(tgid=5)

Casp1↓, 1,   iNOS↓, 1,   MAPK↓, 1,   MAPK↑, 1,   p38↓, 3,   p38↑, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↓, 1,  

Migration(tgid=13)

MMP13↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 2,   IL1β↓, 3,   IL6↓, 2,   Inflam↓, 2,   NF-kB↓, 3,   PGE2↓, 1,   TNF-α↓, 3,  

Drug Metabolism & Resistance(tgid=21)

BioAv↝, 1,   Half-Life↝, 1,  

Clinical Biomarkers(tgid=22)

IL6↓, 2,   LDH↓, 1,  

Functional Outcomes(tgid=23)

cardioP↑, 1,   cognitive↑, 1,   hepatoP↑, 1,   neuroP↑, 1,   radioP↑, 2,   RenoP↑, 1,   toxicity↓, 1,  
Total Targets: 42

Scientific Paper Hit Count for: p38, p38
10 Thymoquinone
8 Allicin (mainly Garlic)
8 Fisetin
8 Quercetin
6 Magnetic Fields
6 Piperlongumine
6 Silymarin (Milk Thistle) silibinin
6 Shikonin
5 Berberine
5 Resveratrol
5 Sulforaphane (mainly Broccoli)
4 Silver-NanoParticles
4 Radiotherapy/Radiation
4 Artemisinin
4 Curcumin
4 Luteolin
4 Vitamin K2
3 Apigenin (mainly Parsley)
3 Betulinic acid
3 Chrysin
3 Lycopene
2 1,8-Cineole
2 Alpha-Lipoic-Acid
2 Ashwagandha(Withaferin A)
2 Baicalein
2 Beta-Caryophyllene
2 Boswellia (frankincense)
2 Carnosic acid
2 Carvacrol
2 Crocetin
2 Ginger/6-Shogaol/Gingerol
2 EGCG (Epigallocatechin Gallate)
2 5-fluorouracil
2 Genistein (soy isoflavone)
2 Hydrogen Gas
2 Juglone
2 Phenylbutyrate
2 Piperine
2 Vitamin C (Ascorbic Acid)
1 Photodynamic Therapy
1 Camptothecin
1 alpha Linolenic acid
1 Ascorbyl Palmitate
1 Trastuzumab
1 α-Bisabolol / Chamomile oil
1 Caffeic acid
1 Capsaicin
1 Chlorogenic acid
1 Carvone
1 D-limonene
1 Disulfiram
1 Eurycomanone
1 Eugenol
1 Evodiamine
1 Ferulic acid
1 Formononetin
1 Gambogic Acid
1 doxorubicin
1 Ginkgo biloba
1 Ginkgolide B
1 Grapeseed extract
1 Magnolol
1 Methyl salicylate / Sweet Birch oil
1 Magnetic Field Rotating
1 Mushroom Chaga
1 Myricetin
1 Naringin
1 Propolis -bee glue
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Phenethyl isothiocyanate
1 Kaempferol
1 raloxifen
1 tamoxifen
1 Rosmarinic acid
1 Sanguinarine
1 Selenium
1 Oxygen, Hyperbaric
1 Selenite (Sodium)
1 Aflavin-3,3′-digallate
1 Urolithin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:235  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page